Big Market Research

Global Breast Cancer Market 2014-2018 by Big Market Research

Big Market Research includes a new report “Global Breast Cancer Market 2014-2018” which forecasts that Global Breast Cancer market would grow at a CAGR of 11.61 % from 2014 to 2018.

 
Repost This

Portland, OR -- (SBWIRE) -- 07/03/2014 -- Breast cancer mostly occurs in females constituting for almost 80 percent of the cases. Invasive Ductal Carcinoma-, a sub-type of Ductal carcinoma, is the most common type of breast cancer. According to a report, a substantial 11.9%of global cancer cases have been those of breast cancer, leading to 522,000 casualties. The major restraint for this market is diagnosis of the cancer in its early stage.

Depending on the type of cancerous tissue, breast cancer is classified as Ductal Carcinoma, Lobular Carcinoma, Nipple Cancer and other undifferentiated carcinoma.

To Get More Information: http://www.bigmarketresearch.com/global-breast-cancer-2014-2018-market

For analyzing revenue generation through therapies and treatments, following major types of breast cancer have been considered:

- HER2-negative breast cancer
- HER2-positive breast cancer
- Hormone receptor positive breast cancer
- Hormone receptor negative breast cancer
- Advanced breast cancer
- Early breast cancer
- Operable node positive breast cancer
- Metastatic breast cancer
- Triple Negative Breast Cancer

The regional breast cancer market is segmented into Americas, EMEA and APAC.

The major vendors in global breast cancer market are Astrazeneca PLC, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG and Sanofi-Aventis.

Other prominent vendors include Accord Healthcare, Inc., Pfizer Inc., Hospira Inc., Actavis Inc., Bayer AG, BioMarin Pharmaceutical, Inc., Bristol-Myers Squibb Company, Celgene Corporation, Celldex Therapeutics, Inc., DARA BioSciences, Inc., Eisai Inc., Galena Biopharma, Inc., Gilead Sciences, Inc., GlaxoSmithKline plc,., Immunovative Therapies, Ltd., Nektar Therapeutics, Nippon Kayaku Co., Ltd., Pierre-Fabre Medicament, ProStrakan Inc., Pt Dexa Medica, Sorrento Therapeutics, Inc., Sun Pharmaceutical Industries Ltd. and Teva Pharmaceutical Industries Ltd.

Browse Similar Reports:

Global Cosmetics Packaging Market 2014-2018 http://www.bigmarketresearch.com/global-cosmetics-packaging-2014-2018-market

Global Baby Food and Infant Formula Market 2014-2018 http://www.bigmarketresearch.com/global-baby-food-and-infant-formula-2014-2018-market

Global Haptic Technology Market http://www.bigmarketresearch.com/haptic-technology-market

About Us:
With the arsenal of different search reports, we help you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.

With the window of opportunity getting open and shut at a speed of light, it has become very important to survive in the market and only the fittest and competent enough can do so. So, we try and provide with latest changes in the market that can suit your needs and help you take decision accordingly.

Contact Us:
Sona Padman
5320 SW Macadam Avenue,
Suite 100,
Portland, OR 97239,
United States.
Direct: +1 (617) 674-4143
Toll Free: +1 (855) 711-1555
Fax: +1 (855) 550-5975
Email: sales@bigmarketresearch.com
Blog: http://www.bigmarketresearch.blogspot.com/
Web: http://www.bigmarketresearch.com